Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
about
Thrombolysis for acute ischaemic strokeInsulin for glycaemic control in acute ischaemic strokeThrombolysis for acute ischaemic strokeAbsolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.Vascular protection to increase the safety of tissue plasminogen activator for strokeAcute Stroke: Current Evidence-based Recommendations for Prehospital CareUpdate of the stroke therapy academic industry roundtable preclinical recommendationsConsidering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial.Intensive insulin therapy for critically ill patients.Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes.Intensive insulin therapy and mortality in critically ill patients.A user's guide to the NINDS rt-PA stroke trial databaseAggressive glucose control for acute ischemic stroke patients by insulin infusion.Intensive versus conventional insulin therapy in critically ill neurologic patients.Diabetes and the brain: issues and unmet needs.Hyperglycemia, acute ischemic stroke, and thrombolytic therapyLack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator.Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS.Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials.Thrombolysis for cerebral ischemiaAn elevated gap between admission and A1C-derived average glucose levels is associated with adverse outcomes in diabetic patients with pyogenic liver abscess.NADPH oxidase-2: linking glucose, acidosis, and excitotoxicity in stroke.Various blood glucose parameters that indicate hyperglycemia after intravenous thrombolysis in acute ischemic stroke could predict worse outcomeHyperglycaemia in patients with acute ischaemic stroke: how often do we screen for undiagnosed diabetes?Hyperglycaemia, insulin therapy and critical penumbral regions for prognosis in acute stroke: further insights from the INSULINFARCT trial.Neurovascular injury in acute hyperglycemia and diabetes: A comparative analysis in experimental stroke.Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamateComparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA.Care of the stroke patient: routine management to lifesaving treatment options.Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide productionHyperglycemia in the hospital setting: the case for improved control among non-diabetics.Elevated Fasting Blood Glucose Is Predictive of Poor Outcome in Non-Diabetic Stroke Patients: A Sub-Group Analysis of SMART.An Elevated Glycemic Gap is Associated With Adverse Outcomes in Diabetic Patients With Community-Acquired PneumoniaTreatment of massive cerebral infarction.Acute stroke and diabetes.Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas.Determinants of outcome in patients eligible for thrombolysis for ischemic stroke.Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic StrokeAssociation of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post-Thrombolysis: Findings From Get With The Guidelines-Stroke.In vivo animal stroke models: a rationale for rodent and non-human primate models.
P2860
Q24194788-D7F9165D-D7E7-49E6-89EF-D9971180E05FQ24201046-1661B7BC-312F-4BB9-B5F5-4C6E53E9E3B4Q24240067-59E37948-CDDA-492F-9804-E36AFBB6BB9CQ26796474-99B82968-074C-4B2F-81B5-CE7BA3F6A1BBQ26824338-275C228B-A101-4761-990B-839626EDD89EQ28069451-D88F896F-E090-48A5-9FC4-E7C34D40DA7AQ29615508-7E261954-4806-4437-8371-386621293128Q30417353-A1872D95-EDDE-4C05-BAE0-DCAF61513DA8Q33203601-A6FDB0E0-B0CD-423B-B387-E857D2D6B27DQ33302694-FEEDEF03-98BB-47FD-AF2D-DBE0E4E74C35Q33321943-A82E8D1D-27E3-4DA2-83A9-B00C83299334Q33336758-5069CEF4-8D73-46ED-A70D-6C182825AF55Q33590729-A51557F5-DA78-4D0C-B6BE-9A750B4A99C7Q33653311-143ED4D8-83BB-4C85-974A-48430CE9A970Q33780337-68863856-4FB3-4B05-AF7C-6EE007F8BAB9Q33954912-DEDC8677-0416-4FEC-BDD7-D9A7FEBAA359Q34051719-D073D4A0-EA9C-41F0-B92D-0F42D49AAFAAQ34130693-1A07A40E-253E-4DD5-B601-F7052C694575Q34130790-F7E470F5-808F-4A58-AAE1-590E70E2B856Q34434829-F9CC38F3-66A0-4437-9F04-CE8135934BB8Q34749605-818FBC91-A041-468A-9F11-976BE86D55B2Q34802636-645DBBE0-AF5F-457D-856A-89119B171E2FQ35152697-217BF03E-DA13-4CAD-ABFB-23C8C8EDC3EAQ35185150-0564964F-068F-43D5-8B63-878BC352FE88Q35201541-F91C87B4-DD83-4BE2-A6D8-D53102539D76Q35202882-D83E6304-57D9-4980-8852-FFC9D5D4981AQ35217410-1D0E32E4-B040-48DD-9384-E090B5E72C9EQ35587581-8255EC10-2298-4FD1-963D-8949D279998AQ35648053-95C23AC4-29AC-4E26-8C89-78121CCAF23FQ36010304-F2EC10CF-DB15-414E-B928-4001269E5C1EQ36035243-8C75DCAB-D2C9-401E-9AAB-40B23AF143A8Q36096015-52A7F52D-C9F8-4464-ABA7-7CD776A99AD7Q36153054-F030E065-2DE0-4E47-B060-98B05FDE9C45Q36303072-9A5849DD-30F3-4847-94D2-B29B9211488AQ36308664-36A7CD05-09A6-4306-82FC-B8345D5DAAB5Q36515347-E59BE940-292D-4374-A7DA-37A7F0EC5B2EQ36536220-6582DF3D-B67D-452D-A537-974ACBA7FA59Q36614594-E1DB7591-3201-4566-BF8F-D0D51416E348Q36835905-549321CC-D6E8-482E-94A8-8E77F164273BQ36839215-EEA70A44-32EA-493C-8C20-DA15C63234FA
P2860
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
@en
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
@nl
type
label
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
@en
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
@nl
prefLabel
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
@en
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
@nl
P2093
P356
P1433
P1476
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
@en
P2093
B C Tilley
J P Broderick
M R Frankel
NINDS rt-PA Stroke Study Group
S E Fineberg
S R Levine
T G Kwiatkowski
P304
P356
10.1212/WNL.59.5.669
P407
P577
2002-09-01T00:00:00Z